|

This National Cancer Institute supported
program provides research training essential to the academic and research base of DNA
damage response. A common theme is the development of novel treatment strategies for
cancer using state-of-the-art translational approaches. The goal is the training of
independent investigators in the molecular basis of DNA damage response and on the ways
this knowledge can be translated to new cancer therapies. The program emphasizes direct
research experience and is supplemented by formal courses, seminars, conferences and by
exposure to the clinical environment.
A dynamic group of widely recognized and well-funded scientists provides an outstanding
training environment. A unique feature is the exposure of trainees to the clinical
environment and assignment to clinician scientists working at the forefront of clinical
cancer research.
Applicants
must have a PhD in the biological, chemical or physical sciences or a MD, DO, DVM, or
comparable degree. The training program consists of 2-3 years of direct laboratory
experience under the supervision of one of the preceptors. After completion trainees will
be prepared to enter independent research careers in modern aspects of cancer research in
a university, government laboratory or industrial research setting.
Applicants
must be permanent residents or citizens of the United States. Please send curriculum vitae
and names of three references to:
Dr. Dennis
Leeper or Dr. George Iliakis
Department of Radiation Oncology
Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, PA 19107
E-mail: dennis.leeper@mail.tju.edu or george.iliakis@mail.tju.edu
|